News

Study shows that PBMs may lead to higher drug prices.

What today’s seniors expect from healthcare-and how you can deliver it.

New study finds that when providers engage patients with HIV, patients respond more favorably.

FDA approved the first and only ready-to-use insulin for IV infusion in hospitals and acute care settings.

Healthcare providers are ready and planning to assume increased levels of risk through commercial payer and Medicare contracting models and Medicare Advantage.

Customized survivorship plans specific to the cancer the patient endured and the treatment they received are essential.

New study shows that more physicians are interested in telemedicine and locum tenens.

Oncologists are under intense pressure to come up with cost savings-and many are turning to value-based care structures.

Why a new study that actively tracks patient quality-of-life could be a big advancement in clinical trials.

New analysis shows what the effect of high-cost health plan taxes could mean.

The lessons healthcare organizations should be learning.

Study finds that the annual cost of risk for third-party vendors in healthcare is $3.8 million.

New tools can help to identify patients at a high risk for HIV but not using PrEP.

A first-ever global study of cardiac rehab centers shows significant improvement is needed.

Patients with overactive bladder taking this OAB drug did not experience an excess risk of CV events compared with other treatments.

Asthma patients may soon treat themselves with first-ever digital maintenance inhaler.

Survey shows that healthcare organizations are falling behind when it comes to prioritizing cybersecurity.

A new article from ACP is designed to help primary care physicians address barriers in transgender medical care.

Why and how the insurance giant is getting into the AI space.

Where and how greater numbers of pharmacists are getting involved at health systems.

While some are concerned that President Trump’s proposed “favored nations” policy would harm pharma makers, one analyst is not as concerned.

While some are concerned that President Trump’s proposed “favored nations” policy would harm pharma makers, one analyst is not as concerned.

EpiPens have been in short supply, but stakeholders are trying to fill in the access gap.

Ranking the best states for healthcare highlights where more work is needed.

Top oncology experts share how they deliver these therapies to patients in need.

The technologies bridging the gap between social care providers and medical care providers.

No longer a pipe dream, AI is already in use. Here are two real-world examples of machine learning in healthcare.

The biobank is now one of the largest in the country.